Rahman et al. [26] implanted human GBM cells in the striatum of immunocompromised mice and treated them with bevacizumab and BMP4 to test whether BMP4 could prevent diffuse tumor infiltration induced by bevacizumab in a malignant glioma xenograft model. This evidence concerns the gene BMP4 and neoplasm.